“The more I thought about it, the more I realized I was against much of the unicorn obsession,” she said....
That’s how Jim Morrow, founder and chief investment officer of Callodine Capital, describes the eventual – inevitable – unwinding of...
Near-term supply chain pressures will cap gains for CoreWeave , according to JPMorgan. The bank downgraded CoreWeave, which provides infrastructure for artificial intelligence firms, to neutral...
Without official Bureau of Labor Statistics data to calm their nerves, analysts are wondering just how fast the U.S. employment market may have deteriorated. While available...
A screendoor is pretty much half a door. Mesh and semi-transparent, screendoors are most associated with sticky summer Sunbelt days, but they’re not fundamentally aesthetic—they’re meant...
Novo Nordisk has a lot on its plate — and it may not all be healthy. The pharmaceutical giant pulled out of its bidding war against...
Amgen CEO Bob Bradway detailed promising results from the company’s recent drug trial, telling CNBC’s Jim Cramer that the medicine can reduce the risk of heart...
A trader works on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Nov. 10, 2025. Brendan McDermid | Reuters Stock...
